A. Sinclair

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry

R. Salazar, A. Maconi, F. Mazzoni, 2022, Journal of the National Cancer Institute.

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, R. Salazar, 2021, The Lancet Oncology.

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

R. Roylance, D. Ottaviani, Y. Wong, 2021, Cancers.

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer

M. Filetti, F. Mazzoni, G. Lyman, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, F. Mazzoni, 2021, The Lancet. Oncology.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.